Narumol Trachu

270 Rama VI Road
Ratchathewi, 10400, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Gut microbiome in advanced non-small cell lung cancer: effect of chemotherapy and impact on efficacy.

Gut microbiome in advanced non-small cell lung cancer: effect of chemotherapy and impact on efficacy.

Journal: Translational lung cancer research

Published: February 19, 2026

Dynamics of the immune repertoire in recurrent, locally advanced NSCLC not amenable for definitive therapy and in stage IV disease receiving first-line chemotherapy.

Dynamics of the immune repertoire in recurrent, locally advanced NSCLC not amenable for definitive therapy and in stage IV disease receiving first-line chemotherapy.

Journal: Frontiers in oncology

Published: January 14, 2026

Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients.

Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients.

Journal: Lung Cancer (Auckland, N.Z.)

Published: November 03, 2025

The impact of systemic inflammatory markers on EGFR-mutant non-small cell lung cancer.

The impact of systemic inflammatory markers on EGFR-mutant non-small cell lung cancer.

Journal: BMC cancer

Published: April 12, 2025

Leukocytes telomere length as a biomarker of adverse drug reactions induced by Osimertinib in advanced non-small cell lung cancer.

Leukocytes telomere length as a biomarker of adverse drug reactions induced by Osimertinib in advanced non-small cell lung cancer.

Journal: Scientific reports

Published: July 13, 2024

Dynamic changes in immune repertoire profiles in patients with stage III unresectable non-small cell lung cancer during consolidation treatment with immunotherapy.

Dynamic changes in immune repertoire profiles in patients with stage III unresectable non-small cell lung cancer during consolidation treatment with immunotherapy.

Journal: BMC cancer

Published: September 05, 2023

Molecular alterations and clinical prognostic factors in resectable non-small cell lung cancer.

Molecular alterations and clinical prognostic factors in resectable non-small cell lung cancer.

Journal: BMC cancer

Published: August 28, 2023

A Phase I Study of the CDK4/6 Inhibitor Palbociclib in Combination with Cetuximab and Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.

A Phase I Study of the CDK4/6 Inhibitor Palbociclib in Combination with Cetuximab and Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 01, 2023

CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients.

CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients.

Journal: Frontiers in pharmacology

Published: May 14, 2023

Six-MicroRNA Prognostic Signature in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma.

Six-MicroRNA Prognostic Signature in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma.

Journal: JCO precision oncology

Published: May 10, 2023

Clinical correlations with EGFR circulating tumor DNA testing in all-stage lung adenocarcinoma.

Clinical correlations with EGFR circulating tumor DNA testing in all-stage lung adenocarcinoma.

Journal: Cancer biomarkers : section A of Disease markers

Published: December 19, 2022

Healthcare coverage affects survival of EGFR-mutant Thai lung cancer patients.

Healthcare coverage affects survival of EGFR-mutant Thai lung cancer patients.

Journal: Frontiers in oncology

Published: September 28, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026